Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy in Infant Acute Lymphoblastic Leukemia
NCT00015873Phase 3Completed
- Sponsor
- Dutch Childhood Oncology Group
- Start
- May 1999
- Primary completion
- Feb 2006
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Replacement Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of vincristine, mercaptopurine, methotrexate, cytarabine, asparaginase escherichia coli in acute lymphoblastic leukemia (ALL), sponsored by Dutch Childhood Oncology Group. Started May 1999; status: completed.
02
Drugs
vincristinemercaptopurinemethotrexatecytarabineasparaginase escherichia coli
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00015873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015873.